Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis

被引:0
作者
Meng, Xiaohui [1 ,2 ]
Sheng, Li [3 ]
You, Yongqing [1 ,2 ]
Dai, Huibo [1 ]
Yu, Manshu [1 ]
Wang, Funing [1 ,2 ]
Zhou, Ziren [1 ,2 ]
Shan, Yun [1 ]
Sheng, Meixiao [1 ]
机构
[1] Nanjing Univ Chinese Med, Dept Nephrol, Affiliated Hosp, Nanjing, Peoples R China
[2] Nanjing Univ Chinese Med, Coll Clin Med 1, Med Res Ctr, Nanjing, Peoples R China
[3] Nanjing Univ Chinese Med, Dept Nephrol, Kunshan Affiliated Hosp, Kunshan, Peoples R China
基金
中国国家自然科学基金;
关键词
traditional Chinese medicine; Qixue Huazheng formula; peritoneal fibrosis; metabolomics; network pharmacology; estrogen signaling; ras signaling; apoptosis; MESENCHYMAL TRANSITION; MESOTHELIAL CELLS; ASTRAGALUS; ESTROGEN;
D O I
10.3389/fphar.2025.1515038
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Peritoneal fibrosis (PF) causes peritoneal dialysis (PD) withdrawal due to ultrafiltration failure. Qixue Huazheng formula (QXHZF), comprising Astragalus membranaceus, Centella asiatica, and Ligusticum sinense, is applied to treat PD-related peritoneum injury related; however, the active components, core genes, and underlying mechanism involved remain unclear.Methods The anti-PF effects of QXHZF were verified in vivo and in vitro. Targets underlying QXHZF-mediated improvement of PD-induced PF were predicted using network pharmacology analysis. Metabolites associated with QXHZF treatment of PD-related PF were analyzed by serum metabolomics. Integration of network pharmacology and serum metabolomics findings identified potentially important pathways, metabolites, and targets, and molecular docking studies confirmed the interactions of key components and targets. Western blotting (WB), quantitative real-time PCR (qRT-PCR), TdT-mediated dUTP Nick-End Labeling (TUNEL) staining, and flow cytometry were conducted.Results QXHZF had potent therapeutic efficacy against PF according to WB, qRT-PCR, and pathological section examination. Network pharmacological analysis indicated that multiple QXHZF compounds contributed to improving PF by modulating various targets and pathways. Differential metabolites were identified by serum metabolomics analysis. Integrated data analysis indicated that steroid hormone biosynthesis, the Ras signaling pathway, apoptosis, and estrogen signaling contributed to the effects of QXHZF. Metabolite-target network and molecular docking analyses revealed that QXHZF can bind to estrogen receptor 1 (ESR1) and rapidly accelerated fibrosarcoma 1 (RAF1) through its components. WB demonstrated that QXHZF treatment reversed activation of the above-mentioned signaling pathways, thereby inhibiting PD fluid-induced PF.Conclusion QXHZF can significantly ameliorate PD-induced PF and may regulate estrogen signaling, the Ras pathway, and apoptosis in this context.
引用
收藏
页数:18
相关论文
共 48 条
[1]   Ethnobotany, phytochemistry, pharmacology, and toxicity of Centella asiatica (L.) Urban: A comprehensive review [J].
Biswas, Dew ;
Mandal, Sujata ;
Chatterjee Saha, Suchismita ;
Tudu, Champa Keeya ;
Nandy, Samapika ;
Batiha, Gaber El-Saber ;
Shekhawat, Mahipal S. ;
Pandey, Devendra Kumar ;
Dey, Abhijit .
PHYTOTHERAPY RESEARCH, 2021, 35 (12) :6624-6654
[2]   Network pharmacology, molecular docking and experimental verification of the mechanism of huangqi-jixuecao herb pair in treatment of peritoneal fibrosis [J].
Dai, Huibo ;
Shan, Yun ;
Yu, Manshu ;
Wang, Funing ;
Zhou, Ziren ;
Sun, Jinyi ;
Sheng, Li ;
Huang, Liyan ;
Sheng, Meixiao .
JOURNAL OF ETHNOPHARMACOLOGY, 2024, 318
[3]   Astragalus Mongholicus: A review of its anti-fibrosis properties [J].
Gong, Fengying ;
Qu, Rongmei ;
Li, Yongchun ;
Lv, Ying ;
Dai, Jingxing .
FRONTIERS IN PHARMACOLOGY, 2022, 13
[4]   Kaempferol inhibits renal fibrosis by suppression of the sonic hedgehog signaling pathway [J].
Guan, Yiqing ;
Quan, Dongling ;
Chen, Kai ;
Kang, Liangqi ;
Yang, Danni ;
Wu, Huanxian ;
Yan, Mengqiu ;
Wu, Shaoyu ;
Lv, Lin ;
Zhang, Guohua .
PHYTOMEDICINE, 2023, 108
[5]   Role of estrogen and RAS signaling in repeated implantation failure [J].
Hong, Kwonho ;
Choi, Youngsok .
BMB REPORTS, 2018, 51 (05) :225-229
[6]   Treatment of peritoneal fibrosis: Therapeutic prospects of bioactive Agents from Astragalus membranaceus [J].
Huang, Ying ;
Chu, Chenling ;
Mai, Yuanyuan ;
Zhao, Yue ;
Cao, Luxi ;
Ji, Shuiyu ;
Zhu, Bin ;
Shen, Quanquan .
FRONTIERS IN PHARMACOLOGY, 2024, 15
[7]   Deletion of p38 MAPK in macrophages ameliorates peritoneal fibrosis and inflammation in peritoneal dialysis [J].
Ikushima, Akie ;
Ishimura, Takuya ;
Mori, Keita P. ;
Yamada, Hiroyuki ;
Sugioka, Sayaka ;
Ishii, Akira ;
Toda, Naohiro ;
Ohno, Shoko ;
Kato, Yukiko ;
Handa, Takaya ;
Yanagita, Motoko ;
Yokoi, Hideki .
SCIENTIFIC REPORTS, 2024, 14 (01)
[8]   Optimization and evaluation of novel tetrahydropyrido[4,3-d] pyrimidine derivatives as ATX inhibitors for cardiac and hepatic fibrosis [J].
Jiang, Nan ;
Zhou, Yuhong ;
Zhu, Minglin ;
Zhang, Junlong ;
Cao, Meng ;
Lei, Hongrui ;
Guo, Ming ;
Gong, Ping ;
Su, Guangyue ;
Zhai, Xin .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 187
[9]   A Longer Duration of Estrogen Deficiency Increases Fibrosis Risk Among Postmenopausal Women With Nonalcoholic Fatty Liver Disease [J].
Klair, Jagpal Singh ;
Yang, Ju Dong ;
Abdelmalek, Manal F. ;
Guy, Cynthia D. ;
Gill, Ryan M. ;
Yates, Katherine ;
Unalp-Arida, Aynur ;
Lavine, Joel E. ;
Clark, Jeanne M. ;
Diehl, Anna Mae ;
Suzuki, Ayako .
HEPATOLOGY, 2016, 64 (01) :85-91
[10]   Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats [J].
Lee, Yong Hee ;
Son, Ji Yeon ;
Kim, Kyeong Seok ;
Park, Yoo Jung ;
Kim, Hae Ri ;
Park, Jae Hyeon ;
Kim, Kyu-Bong ;
Lee, Kwang Youl ;
Kang, Keon Wook ;
Kim, In Su ;
Kacew, Sam ;
Lee, Byung Mu ;
Kim, Hyung Sik .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (15)